Skip to content

Clinical trials

Terminated Phase 1/2 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 1/2 Status: Terminated Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20092
20142
20161
20171
20181
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bellicum Pharmaceuticals2
Ann & Robert H Lurie Children's Hospital of Chicago1
Children's Hospital Los Angeles1
Children's Hospital Medical Center, Cincinnati1
Columbia University1
Gamida Cell ltd1
Indiana University1
Nirmish Shah1
Robin E. Miller1
TRF Pharma, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell13
Hemoglobinopathies3
Thalassemia3
Anemia2
Anemia, Aplastic2
Anemia, Diamond-Blackfan2
Cytopenia2
Fanconi Anemia2
Hematologic Neoplasms2
Leukemia2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.